Metandren, Oreton Methyl (methyltestosterone) is a small molecule pharmaceutical. Methyltestosterone was first approved as Metandren on 1982-01-01. It is used to treat breast neoplasms, delayed puberty, erectile dysfunction, and hypogonadism in the USA. The pharmaceutical is active against androgen receptor.
|Trade Name||Metandren, Oreton Methyl|
|Indication||breast neoplasms, delayed puberty, erectile dysfunction, hypogonadism|
|Drug Class||Steroids (androgens, anabolics)|